Whole-body MRI for the Detection of Metastasis

Norwegian University of Science and Technology0 个研究点开始时间: 2016年3月最近更新: 2016年8月10日

适应症

试验速览

阶段: 不适用
状态: 撤回
发起方: Norwegian University of Science and Technology
主要终点: Number of metastasis in skeleton

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

Develop and optimize protocols for whole body MRI for detection of metastases. Evaluate diagnostic accuracy through application of optimized protocols for screening of cancer patients.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Retrospective

入排标准

年龄范围: 18 Years 至 95 Years（Adult, Older Adult）
性别: Female
接受健康志愿者: 否

入选标准

•Cancer patient

排除标准

•Poor general condition
•Pacemaker or other MRI contraindications

结局指标

主要结局

Number of metastasis in skeleton

时间窗: Baseline and after 6 months

Number of skeleton metastasis will be assessed at the regular clinical follow-up of breast cancer patients with metastatic disease

次要结局

未报告次要终点

研究者

发起方

Norwegian University of Science and Technology

申办方类型

Other

责任方

Sponsor

相似试验

已完成

不适用

Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer MetastasesBreast Cancer

NCT00592462M.D. Anderson Cancer Center32

Unknown

不适用

Improving Diagnosis and Treatment of Metastatic Advanced Prostate CancerAdvanced Prostate Carcinoma

NCT04984395Royal Marsden NHS Foundation Trust50

Unknown

不适用

Computer Assisted Early Detection of Liver Metastases From fMRI MapsMetastatic Colorectal Cancer

NCT00435097Hadassah Medical Organization

进行中（未招募）

不适用

Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition SyndromesLi-Fraumeni Syndrome

NCT02950987Dana-Farber Cancer Institute150

Unknown

不适用

Development and Validation of Advanced MRI Methods for Clinical ApplicationsBrain Tumor

NCT03264300St. Joseph's Hospital and Medical Center, Phoenix220